BR112014006248A2 - compostos de triazolopiridina como inibidores de pde10a - Google Patents
compostos de triazolopiridina como inibidores de pde10aInfo
- Publication number
- BR112014006248A2 BR112014006248A2 BR112014006248A BR112014006248A BR112014006248A2 BR 112014006248 A2 BR112014006248 A2 BR 112014006248A2 BR 112014006248 A BR112014006248 A BR 112014006248A BR 112014006248 A BR112014006248 A BR 112014006248A BR 112014006248 A2 BR112014006248 A2 BR 112014006248A2
- Authority
- BR
- Brazil
- Prior art keywords
- triazolopyridine compounds
- pde10a inhibitors
- compounds
- pde10a
- triazolopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11181752 | 2011-09-19 | ||
| PCT/EP2012/068203 WO2013041472A1 (en) | 2011-09-19 | 2012-09-17 | Triazolopyridine compounds as pde10a inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014006248A2 true BR112014006248A2 (pt) | 2017-04-11 |
Family
ID=46851999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014006248A BR112014006248A2 (pt) | 2011-09-19 | 2012-09-17 | compostos de triazolopiridina como inibidores de pde10a |
Country Status (18)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013043520A1 (en) | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
| US20140235667A1 (en) | 2011-09-22 | 2014-08-21 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
| DK2991984T3 (en) | 2013-04-30 | 2017-05-08 | Hoffmann La Roche | PALLADIUM-CATALYST COUPLING OF PYRAZOLAMIDES |
| TWI652014B (zh) | 2013-09-13 | 2019-03-01 | 美商艾佛艾姆希公司 | 雜環取代之雙環唑殺蟲劑 |
| EP3176168A4 (en) | 2014-07-30 | 2018-05-02 | Mochida Pharmaceutical Co., Ltd. | Pyrazole derivative manufacturing method |
| US9879009B2 (en) | 2014-07-30 | 2018-01-30 | Mochida Pharmaceutical Co., Ltd. | Pyrazole derivative manufacturing method |
| CN107635984B (zh) | 2015-03-11 | 2021-04-13 | Fmc公司 | 杂环取代的二环唑杀有害生物剂 |
| JP6740239B2 (ja) | 2015-03-12 | 2020-08-12 | エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ | 複素環置換二環式アゾール殺有害生物剤 |
| KR20180057716A (ko) | 2015-10-08 | 2018-05-30 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 헤테로사이클-치환된 비시클릭 아졸 살충제 |
| BR112020003481B1 (pt) * | 2017-08-22 | 2023-12-05 | Bayer Aktiengesellschaft | Derivados de heterocicleno, seus usos, formulação agroquímica, e métodos para controlar pragas animais e para proteger sementes ou uma planta germinativa de pragas |
| CN113906024B (zh) | 2019-05-27 | 2023-10-20 | 日本农药株式会社 | 交联部有氮原子的缩合杂环化合物或其盐类及含该化合物的农业园艺用杀虫剂及其使用方法 |
| AR119140A1 (es) | 2019-06-13 | 2021-11-24 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
| CN110396157B (zh) * | 2019-08-07 | 2021-07-30 | 广州市建筑科学研究院有限公司 | 缓释型聚羧酸纳米减水剂及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| WO2005012485A2 (en) | 2003-07-31 | 2005-02-10 | Bayer Pharmaceuticals Corporation | Methods for treating diabetes and related disorders using pde10a inhibitors |
| NL2000397C2 (nl) * | 2006-01-05 | 2007-10-30 | Pfizer Prod Inc | Bicyclische heteroarylverbindingen als PDE10 inhibitoren. |
| WO2010035745A1 (ja) * | 2008-09-25 | 2010-04-01 | 杏林製薬株式会社 | ヘテロ環ビアリール誘導体及びそれらを有効成分とするｐｄｅ阻害剤 |
| WO2010059836A1 (en) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
| WO2010117926A1 (en) * | 2009-04-07 | 2010-10-14 | Schering Corporation | Substituted triazolopyridines and analogs thereof |
| US8017604B2 (en) * | 2009-09-24 | 2011-09-13 | Hoffmann-La Roche Inc. | Imidazopyridines |
| EP3550853A1 (en) | 2009-11-24 | 2019-10-09 | Nokia Technologies Oy | An apparatus |
| TWI485151B (zh) * | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物 |
| TW201200516A (en) * | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
| TWI487705B (zh) * | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物 |
-
2012
- 2012-09-17 CN CN201280045398.XA patent/CN103827114B/zh not_active Expired - Fee Related
- 2012-09-17 EA EA201490599A patent/EA201490599A1/ru unknown
- 2012-09-17 ES ES12759445.5T patent/ES2626801T3/es active Active
- 2012-09-17 MX MX2014003025A patent/MX2014003025A/es active IP Right Grant
- 2012-09-17 WO PCT/EP2012/068203 patent/WO2013041472A1/en active Application Filing
- 2012-09-17 UA UAA201404029A patent/UA108711C2/uk unknown
- 2012-09-17 AU AU2012311713A patent/AU2012311713A1/en not_active Abandoned
- 2012-09-17 KR KR1020147009588A patent/KR101584925B1/ko not_active IP Right Cessation
- 2012-09-17 CA CA2846758A patent/CA2846758C/en not_active Expired - Fee Related
- 2012-09-17 EP EP12759445.5A patent/EP2758396B1/en not_active Not-in-force
- 2012-09-17 JP JP2014531187A patent/JP2014526533A/ja active Pending
- 2012-09-17 SG SG11201400759RA patent/SG11201400759RA/en unknown
- 2012-09-17 BR BR112014006248A patent/BR112014006248A2/pt not_active IP Right Cessation
- 2012-09-17 PE PE2014000366A patent/PE20141553A1/es not_active Application Discontinuation
-
2014
- 2014-03-05 CO CO14047250A patent/CO6900144A2/es unknown
- 2014-03-06 IL IL231403A patent/IL231403A0/en unknown
- 2014-03-17 CL CL2014000641A patent/CL2014000641A1/es unknown
- 2014-03-18 US US14/218,275 patent/US8946427B2/en not_active Expired - Fee Related
- 2014-12-16 US US14/572,312 patent/US9227970B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CL2014000641A1 (es) | 2014-11-14 |
| JP2014526533A (ja) | 2014-10-06 |
| MX2014003025A (es) | 2014-05-28 |
| KR20140075716A (ko) | 2014-06-19 |
| CN103827114A (zh) | 2014-05-28 |
| ES2626801T3 (es) | 2017-07-26 |
| IL231403A0 (en) | 2014-04-30 |
| CO6900144A2 (es) | 2014-03-20 |
| EP2758396A1 (en) | 2014-07-30 |
| US9227970B2 (en) | 2016-01-05 |
| SG11201400759RA (en) | 2014-07-30 |
| AU2012311713A1 (en) | 2014-03-13 |
| PE20141553A1 (es) | 2014-10-30 |
| NZ621597A (en) | 2015-04-24 |
| EP2758396B1 (en) | 2017-03-29 |
| US8946427B2 (en) | 2015-02-03 |
| US20140303141A1 (en) | 2014-10-09 |
| KR101584925B1 (ko) | 2016-01-12 |
| CA2846758A1 (en) | 2013-03-28 |
| CA2846758C (en) | 2017-09-12 |
| EA201490599A1 (ru) | 2014-07-30 |
| US20150099735A1 (en) | 2015-04-09 |
| CN103827114B (zh) | 2016-08-24 |
| WO2013041472A1 (en) | 2013-03-28 |
| UA108711C2 (uk) | 2015-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014006248A2 (pt) | compostos de triazolopiridina como inibidores de pde10a | |
| BR112012031343A2 (pt) | compostos de heteroarila contendo nitrogênio | |
| BR112014026828A2 (pt) | compostos de triazolo como inibidores de pde10 | |
| BR112012024199A2 (pt) | derivados de n-(imidazopirimidin-7-il)-heteroarilamida e seu uso como inibidores de pde10a | |
| BR112014003198A2 (pt) | compostos para o tratamento e profilaxia de doença por vírus sincicial respiratório | |
| ECSP13012667A (es) | Compuestos de triazolopiridina | |
| BR112015004984A2 (pt) | formulações aquosas estáveis de adalimumab | |
| BR112015012919A2 (pt) | novos derivados de piridina | |
| BR112015020795A2 (pt) | derivados de pirazol novos | |
| BR112012017580A2 (pt) | derivados de heteroarila contendo nitrogênio | |
| BR112015009600A2 (pt) | piridina-2-amidas úteis como agonistas cb2 | |
| BR112012026338A2 (pt) | novos derivados de 3,3-dimetil tetrahidroquinolina | |
| BR112015013124A2 (pt) | novos derivados de piridina | |
| BR112015009603A2 (pt) | novos derivados de pirazina | |
| BR112012006531A2 (pt) | derivados de imidazopirimidina ou imidazopiridina como inibidores da fosfodiesterase 10a. | |
| BR112012013847A2 (pt) | novos derivados de indolinona ciclopropano | |
| BR112015012825A2 (pt) | piridopirazinas substituídas como inibidores de syk | |
| BR112014004522A2 (pt) | moduladores de pde10 | |
| BR112014028006A2 (pt) | heterociclos de pirrolidino | |
| BR112014010047A2 (pt) | novos derivados de pirazina | |
| BR112012015984A2 (pt) | composição para melhorar a função cerebral, e, polipeptídeo | |
| RS53783B1 (en) | INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM | |
| BR112014016803A8 (pt) | amidas macrocíclicas como inibidoras de protease | |
| CO6592109A2 (es) | Nueva forma cristalina de un derivado de ciclopropilbenzamida | |
| BR112014012521A2 (pt) | novos derivados de pirrolidina como inibidores de catepsina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |